Assessing the impact of a Cooperative Group Trial on Breast Cancer Care in the medicare population

Journal of Clinical Oncology

Volumn 30, Issue 14, 2012, Pages 1601-1607

  Soulos, Pamela R ^a   Yu, James B ^a   Roberts, Kenneth B ^a   Raldow, Ann C ^a   Herrin, Jeph ^a,b   Long, Jessica B ^a   Gross, Cary P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Health Research and Education Trust   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER REGISTRY; EARLY CANCER; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MEDICARE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; ADJUVANT THERAPY; AGE; BREAST TUMOR; CANCER INVASION; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEGMENTAL MASTECTOMY; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIFE EXPECTANCY; MASTECTOMY, SEGMENTAL; MEDICARE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SEER PROGRAM; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84863749171     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.39.4890     Document Type: Article

References (44)

1. Gross CP, Wong N, Dubin JA, et al: Enrollment of older persons in cancer trials after the Medicare reimbursement policy change. Arch Intern Med 165:1514-1520, 2005 (Pubitemid 41058032)
2. Hutchins LF, Unger JM, Crowley JJ, et al: Under-representation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:2061-2067, 1999 (Pubitemid 30035956)
3. Lewis JH, Kilgore ML, Goldman DP, et al: Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21:1383-1389, 2003 (Pubitemid 46606420)
4. Gross CP, Herrin J, Wong N, et al: Enrolling older persons in cancer trials: The effect of sociodemographic, protocol, and recruitment center characteristics. J Clin Oncol 23:4755-4763, 2005 (Pubitemid 46224079)
5. Trimble EL, Carter CL, Cain D, et al: Representation of older patients in cancer treatment trials. Cancer 74:2208-2214, 1994 (Pubitemid 24304400)
6. Cohen HJ, Muss HB: The Cancer and Leukemia Group B Cancer in the Elderly Committee: Addressing a major cancer need. Clin Cancer Res 12:3606s-3611s, 2006
7. Hughes KS, Schnaper LA, Berry D, et al: Lumpectomy plus tamoxifen with or without irradiation inwomen 70 years of age or older with early breast cancer. N Engl J Med 351:971-977, 2004 (Pubitemid 39166260)
8. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002 (Pubitemid 35176242)
9. Howard-McNatt M, Hughes KS, Schnaper LA, et al: Breast cancer treatment in older women. Surg Oncol Clin N Am 14:85-102, 2005 (Pubitemid 39487189)
10. Gajdos C, Tartter PI, Bleiweiss IJ, et al: The consequence of undertreating breast cancer in the elderly. J Am Coll Surg 192:698-707, 2001 (Pubitemid 32506497)
11. Whelan T: A trial of two questions. J Clin Oncol 20:4135-4138, 2002
12. Carlson RW, McCormick B: Update: NCCN breast cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 3:S7-S11, 2005 (suppl 1)
13. Velanovich V, Gabel M, Walker EM, et al: Causes for the undertreatment of elderly breast cancer patients: Tailoring treatments to individual patients. J Am Coll Surg 194:8-13, 2002 (Pubitemid 34044868)
14. Reference deleted
15. Reference deleted
16. Smith GL, Xu Y, Shih YC, et al: Breast-conserving surgery in older patients with invasive breast cancer: Current patterns of treatment across the United States. J Am Coll Surg 209:425-433.e2, 2009
17. Chagpar AB, Studts JL, Scoggins CR, et al: Factors associated with surgical options for breast carcinoma. Cancer 106:1462-1466, 2006
18. Smith GL, Shih YC, Xu Y, et al: Racial disparities in the use of radiotherapy after breast-conserving surgery: A national Medicare study. Cancer 116:734-741, 2010
19. Nattinger AB, Gottlieb MS, Veum J, et al: Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326: 1102-1107, 1992
20. Farrow DC, Hunt WC, Samet JM: Geographic variation in the treatment of localized breast cancer. N Engl J Med 326:1097-1101, 1992
21. Warren JL, Klabunde CN, Schrag D, et al: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40:IV-3- 18, 2002
22. Smith BD, Gross CP, Smith GL, et al: Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 98:681-690, 2006 (Pubitemid 43821786)
23. Carlson R, McCormick B: Update: Breast cancer guidelines. Presented at the 10th Annual Conference of the National Comprehensive Cancer Network, Hollywood, FL, March 16-20, 2005
24. Klabunde CN, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000 (Pubitemid 32007842)
25. Elixhauser A, Steiner C, Harris DR, et al: Comorbidity measures for use with administrative data. Med Care 36:8-27, 1998 (Pubitemid 128456396)
26. Hughes KS, Schnaper LA, Cirrincione C, et al: Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer. J Clin Oncol 28:69s, 2010 (suppl; abstr 507)
27. Smith-Bindman R, Quale C, Chu PW, et al: Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older? Med Care 44:463-470, 2006 (Pubitemid 43755426)
28. McNutt LA, Wu C, Xue X, et al: Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157:940-943, 2003 (Pubitemid 36555054)
29. Robbins AS, Chao SY, Fonseca VP: What's the relative risk? A method to directly estimate risk ratios in cohort studies of common outcomes. Ann Epidemiol 12:452-454, 2002
30. Institute of Medicine: Initial National Priorities for Comparative Effectiveness Research. Washington, DC, The National Academies Press, 2009
31. Sox HC: Defining comparative effectiveness research: The importance of getting it right. Med Care 48:S7-S8, 2010
32. Sox HC: Comparative effectiveness research: A progress report. Ann Intern Med 153:469-472, 2010
33. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
34. Shen J, Andersen R, Brook R, et al: The effects of payment method on clinical decision-making: Physician responses to clinical scenarios. Med Care 42:297-302, 2004
35. Shahinian VB, Kuo YF, Gilbert SM: Reimbursement policy and androgen-deprivation therapy for prostate cancer. N Engl J Med 363:1822-1832, 2010
36. Yen TW, Kuerer HM, Ottesen RA, et al: Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ. J Clin Oncol 25:3251-3258, 2007 (Pubitemid 47325609)
37. Giordano SH, Duan Z, Kuo YF, et al: Impact of a scientific presentation on community treatment patterns for primary breast cancer. J Natl Cancer Inst 98:382-388, 2006
38. National Institutes of Health Consensus Development Panel: National Institutes of Health Consensus Development Conference statement: Adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst Monogr 30:5-15, 2001
39. Harlan LC, Clegg LX, Abrams J, et al: Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. J Clin Oncol 24:872-877, 2006 (Pubitemid 46638838)
40. Shen Y, Dong W, Feig BW, et al: Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004. Cancer 115:2041-2051, 2009
41. Yen TW, Czypinski LK, Sparapani RA, et al: Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors. Cancer 117:398-405, 2011
42. Howlander N, Noone AM, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2008. Bethesda, MD, 2011
43. Neumann PJ, Tunis SR: Medicare and medical technology: The growing demand for relevant outcomes. N Engl J Med 362:377-379, 2010
44. Institute of Medicine: A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. Washington, DC, The National Academies Press, 2010